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Ultrafiltration (UF) failure is one of the most important causes
of long-term peritoneal dialysis (PD) failure in patients.
Osmotic forces acting across small and ultra-small pores
generate a UF with solutes through the small pore and free
water transport (FWT) through the ultra-small pore. The
ability of glucose to exert an osmotic pressure sufficient to
cause UF is the so-called ‘osmotic conductance to glucose’
(OCG) of the peritoneal membrane. Our study proposes a
simple method to determine both the OCG and FWT. In 50
patients on PD, a Double Mini-Peritoneal Equilibration Test
(Double Mini-PET), consisting of two Mini-PET, was
performed consecutively. A solution of 1.36% glucose was
used for the first test, whereas a solution of 3.86% glucose
was used for the second test. The sodium removal values and
the differences in UF between the two tests were used to
calculate FWT and the OCG. Patients with UF failure showed
significant reductions not only in the OCG and the FWT but
also of UF of small pores. The Double Mini-PET is simple, fast,
and could become useful to evaluate patients on PD in
everyday clinical practice.
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Ultrafiltration (UF) across the peritoneal membrane is one of
the major predictors of outcome and mortality in peritoneal
dialysis (PD) patients.1,2 UF failure (UFF) of peritoneal
membrane is one of the most important causes of PD
failure.3–5 Peritoneal UF, in the early phase, is induced by the
crystalloid osmotic pressure due to glucose. Later, the
peritoneal UF is partially re-absorbed. The total amount of
UF is mainly due to the early phase of a peritoneal dwell
when the osmotic agent is glucose.6 The effectiveness of the
osmotic pressure, due to glucose, to generate UF is the so-
called ‘osmotic conductance to glucose’ (OCG) of the
peritoneal membrane.7 According to the theory of three
pores,8–10 the osmotic forces, mainly acting across small pores
(SP) and ultra-small pores (USP) (which have also been
defined as aquaporins-1) in the peritoneal capillary wall,
generate a UF with solutes through the SP (UFSP) and a UF
without solutes or free water transport (FWT) through the
USP.11,12 On the basis of computer simulation9 and
experimental assessment,13 the FWT was estimated to be
approximately 50% of the peritoneal UF during an
hypertonic (glucose 3.86%) dwell, despite the fact that a
very small percentage (E2%) of the total pore area in the
capillary wall was made up of USP.9
Some causes of UFF have been recognized: (1) high rates
of small solute transport, (2) decreased OCG, (3) high rate of
peritoneal absorption of dialysis fluid, and (4) small
peritoneal surface area.14
The decreased OCG is associated with a markedly reduced
sieving of sodium and it is commonly attributed to an
impairment of the aquaporin-1 function.5
At present, only complicated peritoneal tests7,15 or
computer simulations6 are available to assess OCG.
Recently, we showed a simple and fast method to assess
the FWT by a peritoneal equilibration test (PET) with 3.86%
glucose solution, lasting 1 h (Mini-PET), in a small group of
PD patients [La Milia V et al., Nephrol Dial Transplant 2002;
17(Suppl 3):17–18 (abstract)]. The Mini-PET was sophisti-
cated using an intraperitoneal volume marker and correcting
for sodium diffusion, so that FWT could be calculated at
every time point during a classical 3.86% PET lasting 4 h,16
was validated by computer simulation suggesting also an
algorithm of correction for lymphatic absorption and sodium
diffusion17 and applied in a larger group of PD patients.13
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Furthermore the FWT, calculated by our method, was
correlated to vascular aquaporin-1 expression.18
As demonstrated by Stelin and Rippe,7 on the basis of the
principle of ‘osmotic transients,’19 it is possible to assess the
initial rate of fluid filtration (osmosis) occurring from the
blood to the peritoneal cavity by means of two dwells with
two different glucose concentrations (1.36 and 3.86%),
shortening the dwell time to 1 h,6 and without using
intraperitoneal volume markers or computer-based calcula-
tions. Indeed, assuming that all parameters, but glucose
concentration, remain constant between the two dwells, it is
possible to assess OCG by the difference in initial UF rates
(see Materials and Methods and Appendix).
The aim of this study was to propose a simple method to
assess both OCG and FWT in PD patients. Moreover, the
influence of sodium diffusion on the assessment of FWT was
evaluated.
RESULTS
Table 1 summarizes the peritoneal transport characteristics
during the Double Mini-PET.
As described elsewhere,20–23 the values of dialysate/plasma
creatinine concentration ratio (D/PCreatinine) and mass
transfer area coefficient (MTAC) of creatinine (MTACCreatinine)
were similar when assessed with different glucose concentra-
tions. As expected, UF, the ratio of dialysate glucose
concentrations (D/D0), the MTAC of glucose (MTACGlucose),
the dialysate/sodium concentration ratio (D/PNa), and the
sodium removal (NaR) values of the two Mini-PETs were
different.
The OCG was 3.2871.46 ml/min/mm Hg. According to
OCG values, patients were categorized into four groups
(Figure 1). Eight (16%) patients had an OCG44.74 ml/min/
mm Hg, 12 (24%) patients had values of OCG between 3.30
and 4.74 ml/min/mm Hg, 22 (44%) patients had values of
OCG between 1.82 and 3.29 ml/min/mm Hg, and 8 (16%)
patients had an OCGo1.82 ml/min/mm Hg.
No correlation between OCG and MTACGlucose (r
2¼ 0.007,
P¼ 0.5583) and between OCG and MTACCreatinine (r2¼ 0.001,
P¼ 0.7970) was found.
The UFSP and FWT were 2517133 and 243779 ml,
respectively (Figure 2), and each contributed to approxi-
mately 50% of total UF.
The linear correlation coefficient between UF, during the
classical 3.86%-PET (lasting 4 h), MTACCreatinine and OCG
was good but not very high (r2¼0.15, Po0.01 and
r2¼ 0.16, Po0.01, respectively). The multiple linear correla-
tion analysis between UF, during the classical 3.86%-PET,
and both MTACCreatinine and OCG, as covariates, showed a
better correlation (r2¼ 0.27, Po0.01).
The dialysate sodium concentration during the 1.36%-
Mini-PET was analyzed to evaluate the sodium diffusion.
During the 1.36%-Mini-PET, the so-called sodium sieving
was observed, and this indicates the presence of FWT also
during a dwell with a slightly hyperosmotic solution. The
reduction of dialysate sodium concentration during the
1.36%-Mini-PET was 2.272.2 mmol/l; the dialysate sodium
concentration increased only in eight patients (mean
increase¼ 1.171.0 mmol/l). After correcting for the con-
vective transport, a positive amount of sodium diffusion
during the 1.36%-Mini-PET was present only in five patients
and the difference of UFSP (calculated with and without
sodium diffusion) was 20 ml.
Table 1 | Peritoneal transport characteristics of 50 patients in
PD therapy assessed during the Double Mini-PET
1.36%-Mini-PET 3.86%-Mini-PET P-value
UF (ml) 99795 4947171 o0.0001
UFR (ml/min) 1.371.3 6.672.3 o0.0001
D/D0 0.6170.06 0.5170.05 o0.0001
MTACGlucose (ml/min) 15.273.6 20.673.6 o0.0001
D/PCreatinine 0.3970.08 0.3870.08 0.0856
MTACCreatinine (ml/min) 11.7 (10.8–16.1) 12.1 (9.9–16.5) 0.6894
D/PNa 0.9470.02 0.8870.03 o0.0001
NaR (mmol) 8.0 (0.9–12.6) 34.9 (21.0–45.0) o0.0001
D/D0, ratio of dialysate glucose concentrations at end and at start of tests;
D/PCreatinine, dialysate/plasma creatinine concentration ratio; D/PNa, dialysate/plasma
sodium concentration ratio; MTACGlucose, mass transfer area coefficient of glucose;
MTACCreatinine, mass transfer area coefficient of creatinine; NaR, sodium removal
during the tests; PD, peritoneal dialysis; PET, Peritoneal Equilibration Test; UF,
peritoneal ultrafiltration at end of tests; UFR, peritoneal ultrafiltration rate.
Data are expressed as means71 s.d. or as median values and interquartile ranges in
the parenthesis.
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Figure 1 | Groups of patients according to osmotic conductance
to glucose (OCG) assessed with the Double Mini-PET.
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Figure 2 | UF, UFSP and FWT during the 3.86% test of Double
Mini-PET. UF, ultrafiltration; UFSP, ultrafiltration through small pores;
FWT, free water transport.
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In all patients, the UFSP and FWT after correction for
sodium diffusion were nearly identical to UFSP and FWT
calculated without sodium diffusion (2497134 vs 2517133
and 244776 vs 243779 ml, respectively).
To explore the possible clinical application of the Double
Mini-PET, we analyzed the patients with UFF. Among the 50
patients, 4 had UFF according to the results of the previously
performed classical 3.86%-PET lasting 4 h (i.e., total UF
o400 ml after 4 h of 3.86%-PET). The only differences
observed between the patients with UFF and the patients
with normal peritoneal UF were the lower age (median
age¼ 47 years, range¼ 27–55 years vs median age¼ 62 years,
range¼ 31–82 years) and the longer time on PD treatment
(median time¼ 42 months, range¼ 19–61 months vs median
time¼ 5 months, range¼ 2–159 months) in UFF patients.
During the 3.86%-Mini-PET, the UF was 180784 ml in the
patients with UFF and 5217147 ml (Po0.0001) in the
patients without UFF (Figure 3b). The OCG was
0.9870.48 ml/min/mm Hg in the patients with UFF and
3.4871.34 ml/min/mm Hg (P¼ 0.0006) in the patients
without UFF (Figure 3a).
The patients with UFF showed not only a significant
reduction of FWT but also a significant decrease of UFSP.
The FWT was 112769 ml in the patients with UFF and
254770 ml (P¼ 0.0030) in the patients without UFF (Figure
3d); the UFSP was 68748 ml in the patients with UFF and
2677126 ml (P¼ 0.0030) in the patients without UFF
(Figure 3c). All the patients with UFF belonged to the group
of patients with the lowest levels of OCG, but also some of
the patients without UFF belonged to the same group;
however, an OCG 41.81 ml/min/mm Hg was never asso-
ciated with UFF (Figure 3a).
The D/D0, MTACGlucose, D/PCreatinine, and MTACCreatinine
values assessed during the Double Mini-PET were only
slightly higher in the patients with UFF in comparison with
the patients without UFF (Figure 4).
DISCUSSION
The possibility to estimate the characteristics of the transport
through the peritoneal membrane could be a useful tool to
explore the complex physiology of the peritoneal membrane.
However, the tests to assess some of these mechanisms are
extremely complex and they cannot be applied in everyday
clinical evaluation of patients on PD. Until now, OCG was
assessed only with complicated tests and complex calcula-
tions. We described previously the 3.86%-Mini-PET as a
simple and fast method to assess the FWT in PD patients.13
This study is an extension of the study on 3.86%-Mini-
PET and its aim is to propose a simple method to assess
simultaneously FWT, OCG, and the classical parameters of
peritoneal membrane small solute transport as D/D0, D/P,
and MTAC in PD patients. Moreover, the influence of
sodium diffusion on the assessment of FWT was evaluated.
In this study, after performing a Double Mini-PET in 50
PD patients, we calculated the OCG and FWT with the only
aid of a hand calculator. To our knowledge, this is the first
simple test that allows one to assess the OCG, UFS, FWT, and
the classical parameters of peritoneal small solute transport
(D/D0, D/P, and MTAC) simultaneously.
The analysis of the classical parameters of peritoneal small
solute transport, assessed with the two tests (a 1.36%-Mini-
PET and a 3.86%-Mini-PET) that compose the Double Mini-
PET, showed that the results were similar to the findings of
previous studies that had compared this transport during a
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Figure 3 | Difference of (a) OCG, (b) UF, (c) UFSP and (d) FWT between the PD patients with and without UFF during the Double
Mini-PET. OCG, osmotic conductance to glucose; UF, ultrafiltration; UFSP, ultrafiltration through small pores; FWT, free water transport; UFF,
ultrafiltration failure. UF, UFSP, and FWT were calculated during the 3.86% test of Double Mini-PET. *P¼ 0.0006 vs no UFF; **Po0.0001 vs no
UFF; yP¼ 0.0030 vs no UFF; yyP¼ 0.0030 vs no UFF.
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PET lasting 4 h with different glucose concentrations in the
fresh PD fluid.20–23 Indeed, the D/PCreatinine and MTACCreatinine
were not different during the two tests with different glucose
concentration. As expected, UF, D/PNa, and the parameters of
glucose transport (D/D0 and MTACGlucose) were different with
the two different solutions. These results indicate that the
peritoneal transport of small solutes during a short PET and
during a classical PET lasting 4 h is similar.
The OCG has been rarely assessed in PD patients, and it is
not yet known if the reduction of OCG could be due to a
reduced function of USPs (aquaporin-1 channels) or to a
global reduction of PD membrane pores function or to other
mechanisms.
Stelin and Rippe7 found an mean OCG 3.5472.90 ml/min/
mm Hg in 12 PD patients without UFF. This value is near to
the mean value found in our patients (3.2871.46 ml/min/mm
Hg). Waniewski et al.15 reported a mean OCG 5.8 ml/min/
mm Hg in patients without UFF and of 3.7–4.4 ml/min/mm
Hg in patients with UFF, but the study was performed with
an intraperitoneal volume marker and the method used was
different from the method used in this study. Finally, the
OCG values obtained with the Double Mini-PET were in the
range of the values reported by computer simulations for the
PD patients.6
The results of our study showed that the inclusion of both
MTACCreatinine and OCG, as covariates, increased the variance
in UF capacity of peritoneal membrane (assessed by the
classical 3.86%-PET) from 15 (MTACCreatinine alone) to 27%
(MTACCreatinine and OCG). In conclusion, OCG could
explain a relevant part of variability in the UF capacity of
peritoneal membrane.
According to computer calculations9 and as shown
previously,13 the USP and the FWT each contribute for
approximately 50% to the total UF. One possible criticism to
our method may be the absence of correction for sodium
diffusion in the assessment of FWT;16,17 however, the absence
of correction for sodium diffusion has been demonstrated to
result just in a slight underestimation of FWT.17 It can be
hypothesized that in patients with UFF, the diffusive
transport of sodium could be higher than in patients without
UFF, because in patients with UFF, the increase of MTAC of
small solutes (and then also the MTAC of sodium) is
frequent. It is difficult to assess the MTAC of sodium, as
shown by several studies that reported values of MTAC of
sodium much lower than the theoretical ones,6 because there
are small differences of sodium concentrations between
plasma and dialysate. We were not able to calculate the
MTAC of sodium in this study (not only during the 3.86%-
Mini-PET but also during the 1.36%-Mini-PET); however,
during the 1.36%-Mini-PET, we used the NaR, corrected for
the convective transport, to correct the quantification of
UFSP and FWT for sodium diffusion: UFSP and FWT were
similar with and without the correction for sodium diffusion.
These data confirm that our method only slightly
underestimated the quantification of FWT, also in patients
with UFF (mean difference of 20 ml).
The correction for sodium diffusion could be important
to quantify UFSP and FWT during the classical 3.86%-PET
lasting 4 h; however, the correction for sodium diffusion
should not influence the quantification of UFSP and FWT
during the Mini-PET or the Double Mini-PET, because the
diffusive transport of sodium is low during a very short
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Figure 4 | Difference of D/D0 (a), MTACGlucose (b), D/PCreatinine (c) and MTACCreatinine (d) between the PD patients with and without UFF
during the Double Mini-PET. D/D0, ratio of dialysate glucose concentrations; MTAC, mass transfer area coefficient; D/P, dialysate/plasma
concentration ratio; UFF, ultrafiltration failure. D/D0, D/P, and MTACs were calculated during the 1.36% test of Double Mini-PET: *P¼ 0.3643 vs
no UFF; **P¼ 0.3099 vs no UFF; yP¼ 0.1064 vs no UFF; yyP¼ 0.0759 vs no UFF.
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dwell. In any case, UFSP and FWT values could be corrected
with a simple algorithm.17
In spite of the small number of patients with UFF in our
study, we may deduce some interesting considerations about
the mechanism of UFF. In all the patients with UFF, we found
a marked reduction of OCG. The decrease of OCG was
associated not only with a reduction of FWT but also of
UFSP. In other words, in patients with UFF, the reduction of
OCG was not a selective alteration of aquaporin-1, but was
associated with a global reduction of UF capacity of SPs and
USPs, that is the pores that contribute to UF formation under
an osmotic pressure. This is in agreement with computer
simulations suggesting that aquaporins are unlikely to be
affected in marked UFF.24,25 In contrast, Monquil et al.26
examined a group of six PD patients with UFF that was
attributed to an impairment of transcellular water transport
or FWT because of the reduced difference in net UF obtained
with a PET with glucose 1.36% and a PET with glucose 3.86%
PD solutions. However, the difference in net UF that was
obtained with the two PETs (with glucose 1.36% and with
glucose 3.86%) was not a measure of FWT but only a
difference in total UF between the two tests, due to UF
through the SPs and the USPs;13 so the difference in net UF
of two PETs with different glucose concentrations is an
indirect measure of OCG.6
The Double Mini-PET allowed one to assess directly the
OCG, UFSP, and FWT. The slight underestimate of FWT,
given by our method, supports the conclusion that in
patients with UFF, the FWT and UFSP are both affected when
the OCG is decreased. The finding of only a 50% decrease in
net UF in the absence of sodium sieving27 in aquaporin-1-
deficient mice is another point that further supports this
conclusion. According to our data, in PD patients with UFF,
there were no differences or only slight increase in
MATCCreatinine and MTACGlucose values. All the patients with
UFF had decreased OCG levels, normal or slight increased
values of small solute diffusion and, owing to glucose, not
decreased intraperitoneal osmotic pressure. Considering our
data, the UFF could not be due to an increased peritoneal
surface area (neoangiogenesis)5 alone because, in that case,
also the total area of pores, OCG, and then UF should have
been increased.6 In our study, the peritoneal UF, in the early
phase, was reduced in the patients with UFF and no
correlation was found between small peritoneal solute
transport (MATCCreatinine and MTACGlucose) and OCG.
Furthermore, in another study,18 the patients with a high
peritoneal transport showed no difference in endothelial
aquaporin-1 expression in comparison with low transporters.
However, this issue needs to be clarified evaluating the
parameters of peritoneal membrane function in a large
cohort of PD patients. Mateijsen et al.28 in a histological
study observed a time-related increase of neoangiogenesis in
the peritoneal membrane in PD patients, whereas the recent
study by Williams et al.29 demonstrated a marked increase in
the fibrosis observed in the sub-mesothelial compact zone
and a marked increase in vasculopathy below the compact
zone after several years of chronic exposure to PD fluids. In
patients with UFF, it is possible that the association between
the increasing abnormal microvasculature, produced by
neoangiogenesis, and the fibrosis results in a decreased
osmotic UF.30
The Double Mini-PET allows the simultaneous assessment
of the OCG, FWT, and of the classical parameters of PET (D/
D0, D/PCreatinine, MTACGlucose, MTACCreatinine, and D/PNa)
12
and it can be easily performed in whatever clinical context,
because it does not require the use of intraperitoneal markers
or complex computer calculations. These characteristics
could facilitate the implementation of the evaluation of
peritoneal membrane to a large PD patient’s population and
so could help to understand the mechanisms underlying the
peritoneal membrane’s failure.
Furthermore, the parameters obtained with the double
Mini-PET can help the physicians in the correct prescription
of PD therapy. For example, in the case of severe decrease of
OCG, it is not useful to prescribe a higher glucose
concentration in the PD solutions or a reduction of the time
of the dwell, but it is more appropriate to prescribe an
alternative osmotic agent like icodextrin; in the case of a
‘normal’ UF, OCG, and FWT, with a negative peritoneal UF
during the long dwell (i.e., in CAPD), it is useful to prescribe
a reduction of dwell time with the aid of automated PD.
Finally, the parameters obtained with the Double Mini-
PET are easily applicable to the short time of automated PD
therapy, which is becoming available worldwide.
In conclusion, the Double Mini-PET is a new, simple, and
fast method to assess OCG, UFSP, and FWT, in addition to
the classical parameters of PET. The Double Mini-PET could
become a useful tool for periodical clinical evaluation of PD
patients in everyday clinical practice. Further studies are
required to determine the normal or pathological values of
the classical parameters of the PET (UF, OCG, UFSP, and
FWT) with this method.
MATERIALS AND METHODS
Patients
After having given their informed consent, 50 PD patients (20 males
and 30 females with a mean age of 59714 years) were enrolled into
the study and underwent the Double Mini-PET. The median time
on PD was 5 months (3–21 months). Their condition was stable, and
at the time of test, they had been free of peritonitis for at least
4 weeks. All patients used commercially available PD solutions. All
patients had previously undergone a classical 3.86%-PET (4 h long),
and the median time between the 3.86%-PET and the Double Mini-
PET was 0 month (0–5 months). Four patients had shown UFF
according to the results of the 3.86%-PET (UFo400 ml).
Procedure
The first Mini-PET was performed with a 1.36% glucose solution
and the second Mini-PET with a 3.86% glucose solution. The two
solutions used in the Double Mini-PET were different only in
glucose concentration (1.36 and 3.86%); all other solutes had the
same concentrations. Each Mini-PET lasted 1 h, and they were
performed consecutively in the same morning.
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In all the cases, the dwell before the Double Mini-PET (the
overnight dwell) was performed using a PD solution containing a
glucose concentration of 1.36% with lactate as the buffer; the
overnight solution was instilled at approximately 23:00 hours in the
evening before the test and was drained at about 07:00 hours.
After the overnight drain, a fresh 2 l 1.36% glucose solution was
infused in 10 min. The fresh PD fluid samples were taken from the
bags at the end of the infusion. After the complete infusion of PD
solution, and after having flushed back 30 ml of dialysate, 20 ml
dialysate samples were taken after 1, 30, 60 min and after the
complete dialysate collection by gravity for at least 20 min. After the
1.36% drain, a fresh 2 l 3.86% glucose solution was infused in
10 min and samples of fresh fluid and dialysate were taken with the
same modality; the 3.86% dialysate was collected by gravity for at
least 20 min as well. Blood samples were taken between the two tests.
The volume of the infused fresh PD solution and the drained
dialysate was measured by weighing the bags and then subtracting
the weight of the empty bags; no corrections were made for the
differences in the specific weight of the solutions.
Analytical methods
Plasma and dialysate creatinine, total protein, and glucose
concentrations were analyzed using a Hitachi 717 instrument
(Hitachi, LTD, Tokyo, Japan); an enzymatic method was used to
analyze creatinine to eliminate the effect of the high dialysate
glucose concentration on the measurement of creatinine concentra-
tions in the dialysate. The total sodium concentrations in the
plasma, fresh PD solution, and dialysate were analyzed twice using
an IL 943 flame photometer (Instrumentation Laboratory, Milan,
Italy); the plasma-ionized sodium concentrations were analyzed
using a direct ion-selective electrode (Stat Profile M, Nova
Biomedical Corp., Waltham, MA, USA).
Calculations
D/D0 was calculated dividing the dialysate glucose concentrations at
the end of each Mini-PET by that of the fresh PD solution.
D/PCreatinine and D/PNa were calculated at the end of each Mini-PET;
31
the plasma water concentration of creatinine was considered.32
MTACCreatinine and MTACGlucose were calculated by the simplified
model of Garred33 and to assess the MTAC during the test with
3.86% a value of F¼ 0.5 was used because of the high UF.34
The OCG is equal to the local hydraulic conductivity (Lp)
multiplied by the membrane surface area (S) of pores and by the
coefficient of glucose reflection (s) (LpSs).
6,7
Based on the principle of ‘osmotic transients,’19 it is possible to
asses LpSs (see Appendix for the calculations):
OCG ¼ LpSs ðml=min=mmHgÞ ¼ V3:86  V1:36
19:3ðG3:86  G1:36Þt
 
1:7
where V3.86 and V1.36 are the volume (ml) of drained dialysate with
3.86 and 1.36% glucose solution, respectively, during the Double
Mini-PET; 19.3 (mm Hg/mmol/l) is the product of absolute
temperature and the gas constant at 371C; G3.86 and G1.36 are the
molar glucose concentrations (mmol/l) of the fresh PD solutions
and were calculated as:
Glucose ðmmol=lÞ ¼ glucose ðmg=dlÞ=18
t is the time of the dwells; in all Double Mini-PET, we considered
the effective dwell time as the sum of the 60 min of dwell time, with
a full fill volume (2 l), and the 50% of the time used for instillation
and drainage; 1.7 was a correction factor to correct the dilution of
glucose concentration, due to the peritoneal residual volumes, and
to correct the differences in dialysate volumes between the 1.36%
test and the 3.86% test that were assessed after 60 min (or more) and
not at the beginning of the dwell.6
During the Double Mini-PET, the results of the 3.86%-Mini-PET
were used to calculate the FWT as described previously:13
FWT ðmlÞ ¼ Total UF ðmlÞ  UFSP ðmlÞ
During the 3.86%-Mini-PET, UFSP was calculated as follows:
UFSP ðmLÞ ¼ ½NaR ðmmolÞ1000=Nap ðmmol=lÞ
where NaR (mmol) was calculated as
½VolumeDialysateOut ðLÞNaDialysateOut ðmmol=lÞ
 ½VolumeDialysateIn ðLÞNaDialysateIn ðmmol=lÞ
and Nap was the ionized sodium plasma water concentration
assessed by direct ion-selective electrode.
Moreover, to correct the UFSP for the sodium diffusion, we
calculated the NaR total (NaRT) during the 1.36%-Mini-PET. This is
because during a dwell with 1.36% glucose solution, the UF is low
and therefore the sodium transport is mainly diffusive; however, we
corrected the diffusive transport of sodium for the convective
transport when the UF was positive. The NaR convective (NaRC),
during the 1.36%-Mini-PET, with approximation, was calculated as
NaRC ¼ UF ðLÞNaDialysateOut ðmmol=lÞ
The NaR diffusive (NaRD), during the 1.36%-Mini-PET, was
calculated as
NaRD ðmmolÞ ¼ NaRT ðmmolÞ  NaRC ðmmolÞ
Finally, we corrected the NaR (calculated during the 3.86%-Mini-
PET) for sodium diffusion (calculated during the 1.36%-Mini-PET) as
NaR ðcorrected for sodium diffusionÞ ðmmolÞ
¼ NaR ðcalculated during 3:86%  Mini  PETÞ ðmmolÞ
 NaRD ðcalculated during 1:36%  Mini  PETÞ ðmmolÞ
The NaR corrected for sodium diffusion was used to correct UFSP
and FWT for sodium diffusion.
Statistical analysis
The data with normal distribution were expressed as mean values71
s.d. Median values and interquartile ranges were given for
asymmetrically distributed data.
The same parameters of the two Mini-PETs (1.36%-Mini-PET
and 3.86%-Mini-PET) during the Double Mini-PET were compared
by t-test for paired data.
Mean values71 s.d. of OCG were used to categorize PD patients,
as reported elsewhere.31
Pearson linear correlation analysis was used to investigate
possible relationships between OCG and MTACCreatinine, and
between OCG and MTACGlucose. Furthermore, Pearson linear
correlation analysis was used to investigate possible relationships
between UF, during the classical 3.86%-PET, MTACCreatinine, and
OCG; multiple linear correlation analysis was used to investigate the
possible relationships between UF, during the classical 3.86%-PET,
and MTACCreatinine and OCG as covariates.
The parameters of the patients with and without UFF were
compared by analysis of variance.
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A Po0.05 was considered significant. All the statistical analyses
were performed using JMP 4.0.0 statistical software (SAS Institute
Inc., Cary, NC, USA).
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Appendix
Calculation of osmotic conductance of peritoneal membrane
to glucose. To calculate the osmotic conductance of
peritoneal membrane to glucose, we used the method
previously described by Stelin and Rippe.7
During the peritoneal dialysis with glucose as osmotic agent
the change rate that occurs in peritoneal volume in a given
moment (dV/dt) is equal to net trans-peritoneal volume flow
(JV) and can be described by the following equation
6,7:
dV=dt ¼ JV
¼ LpSðDP  sprotDppprotþsgDpg

Xn
i¼1
siDpiÞ  L ð1Þ
where V, intraperitoneal volume; t, the time; LP, the local
hydraulic permeability; S the membrane surface area; DP the
transcapillary hydrostatic pressure gradient; sprotDpprot the
transcapillary colloid osmotic pressure gradient exerted by
protein; sg the average of osmotic reflection coefficient for
glucose across the peritoneum; Dpg the ideal peritoneal
crystalloid osmotic pressure difference exerted by glucose
across a semi-permeable membrane; L the lymph flow;
Xn
i¼1 siDpi¼ sum of all other effective crystalloid
osmotic gradients acting across the peritoneal membrane:
The term LpSsg is the so-called osmotic conductance to
glucose (OCG) of peritoneal membrane; it is a typical
lumped parameter, which comprises at least two other
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parameters that are not directly measured: hydraulic perme-
ability of the membrane (LpS) and the reflection coefficient
for glucose (sg). The evaluation of these primary parameters
is not possible in clinical settings.
Based on the principle of ‘osmotic transient,’19 it is
possible to assess LpSsg.
If the initial rate of JV, due to osmosis, is assessed for two
different glucose concentrations (e.g., 1.36 and 3.86%) and if
the dwell time is shortened, for example, to 60 min and if all
other parameters, excepts for the glucose concentration,
remained constant between the two dwell, the differences in
initial JV (DJV0) can be described by
6,7
DJV0 ¼ LpSsgðDpg2  Dpg1Þ ð2Þ
where Dpg1 is the ideal (van’t Hoff ’s) transperitoneal osmotic
pressure gradient caused by the first glucose concentration
and Dpg2 that produced by the second glucose concentration.
According to van’t Hoff ’s law,
Dpg2  Dpg1 ¼ DCpg21RT ð3Þ
where RT is the product of absolute temperature and the gas
constant (19.3 mm Hg/mmol/l) at 371C and DCg21 is the
molar difference between the initial glucose concentrations of
the two solutions.
Assuming that the blood glucose concentration is constant
between the two dwell, combining (2) and (3):
DJV0 ¼ LpSsg RTðCg1  Cg2Þ ð4Þ
Rearranging equation (4):
LpSsg ¼ DJV0
RTðCg2  Cg1Þ ¼
Vð60Þ3:86%  Vð60Þ1:36%
19:3ðCg2  Cg1Þ ð5Þ
By (5) it is possible to determine the osmotic conductance to
glucose (OCG or LpSsg). However, because we did not take
into account the initial dilution of instilled glucose
concentration with the residual volume and because we did
not measure initial JV0 but the drained dialysate volume after
60 min of dwell, the value of osmotic conductance to glucose
needs for a correction factor of 1.7.6
Calculation of free water transport across the peritoneal
membrane. The calculation of free water transport across
the peritoneal membrane is reported elsewhere.13
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